Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 15 of 8073 results

  1. Secukinumab for treating moderate to severe hidradenitis suppurativa [ID4039]

    In development [GID-TA11095] Expected publication date: 06 December 2023

  2. Epilepsies in children young people and adults update

    In development [GID-QS10162] Expected publication date: 07 December 2023

  3. Dupilumab for treating prurigo nodularis [ID4054]

    In development [GID-TA11081] Expected publication date: 13 December 2023

  4. Velmanase alfa for treating alpha mannosidosis [ID800]

    In development [GID-HST10010] Expected publication date: 13 December 2023

  5. Pembrolizumab plus chemotherapy with or without bevacizumab for persistent recurrent or metastatic cervical cancer rapid review of TA885 [ID6279]

    In development [GID-TA11448] Expected publication date: 13 December 2023

  6. Transition from children's to adults' services update

    In development [GID-QS10180] Expected publication date: 14 December 2023

  7. Middle Meningeal Embolisation for Chronic Subdural Haematomas CSDH

    In development [GID-IPG10215] Expected publication date: 14 December 2023

  8. Asthma diagnosis monitoring and chronic asthma management

    In development [GID-NG10186] Expected publication date: 30 October 2024

  9. Vitamin B12 deficiency in over 16s diagnosis and management

    In development [GID-NG10176] Expected publication date: 06 March 2024

  10. Cardiovascular disease risk assessment and reduction including lipid modification Escalation of Therapy

    In development [GID-NG10368] Expected publication date: 19 December 2023

  11. Targeted release budesonide for treating IgA nephropathy [ID1434]

    In development [GID-TA11028] Expected publication date: 20 December 2023

  12. Empagliflozin for treating chronic kidney disease [ID6131]

    In development [GID-TA11170] Expected publication date: 20 December 2023

  13. Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education (NG213)

    This guideline covers support for disabled children and young people with severe complex needs, from birth to 25 years. It aims to encourage education, health and social care services to work together and provide more coordinated support to children and young people, and their families and carers.

  14. Integrated health and social care for people experiencing homelessness (NG214)

    This guideline covers providing integrated health and social care services for people experiencing homelessness. It aims to improve access to and engagement with health and social care, and ensure care is coordinated across different services.

  15. Social work with adults experiencing complex needs (NG216)

    This guideline covers the planning, delivery and review of social work interventions for adults who have complex needs. It promotes ways for social work professionals, other care staff and people with complex needs to work together to make decisions about care and support.